A study of usefulness of plasma lyso-GL-3 as a biomarker in patients with Fabry disease
Not Applicable
Recruiting
- Conditions
- Fabry disease
- Registration Number
- JPRN-UMIN000037839
- Lead Sponsor
- Osaka University Graduate School of Medicine, Division of Health Science, Child Healthcare and Genetic Science Laboratory
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who received before, are receiving now or are scheduled to receive Hematopoietic Stem Cell Transplantation / Chaperone therapy. 2) Patients who are considered as ineligible for the study by the investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To investigate correlation between plasma lyso-GL-3 and clinical features as follows; Plasma GL-3, eGFR, Urinary protein-to-creatinine ratio, BNP, LV mass index, EF, Presence of cardiac hypertrophy, Urinary mulberry body
- Secondary Outcome Measures
Name Time Method